Excimer Laser Coronary Angioplasty in Coronary Lesions Use and Safety From the NCDR/CATH PCI Registry

被引:16
|
作者
Sintek, Marc [1 ]
Coverstone, Edward [2 ]
Bach, Richard [1 ]
Zajarias, Alan [1 ]
Lasala, John [1 ]
Kurz, Howard [1 ]
Kennedy, Kevin [3 ]
Singh, Jasvindar [1 ]
机构
[1] Washington Univ, 660 S Euclid,Campus Box, St Louis, MO 63110 USA
[2] Mercy Hosp South, St Louis, MO USA
[3] St Lukes Hlth Hosp, Mid Amer Heart Inst, Kansas City, MO USA
关键词
coronary artery disease; death; dissection; lasers; percutaneous coronary intervention; IN-STENT RESTENOSIS; BALLOON ANGIOPLASTY; ROTATIONAL ATHERECTOMY; INTERVENTION; MECHANISMS; DEVICES;
D O I
10.1161/CIRCINTERVENTIONS.120.010061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Excimer laser coronary angioplasty (ELCA) uses an ultraviolet laser catheter for the treatment of coronary artery disease. ELCA has been used for various coronary lesions, but current safety and frequency of use are unknown. Methods: We performed a retrospective, registry-based study of ELCA use during coronary interventions reported to the National Cardiovascular Data Registry/CATH percutaneous coronary intervention registry from 2009 to 2018 (n=6 043 596 total interventions evaluated). The primary safety end point was the combination of any perforation, dissection, tamponade, or death. ELCA use per 10 000 interventions was evaluated for the study duration. Subgroups of interest were identified including in-stent restenosis lesions, saphenous vein graft lesions, chronic total occlusions, and thrombotic lesions. Results: A total of 19 688 lesions were identified with ELCA use (0.3% of all lesions). The rate of ELCA use increased across the study period from 14 ELCAs performed per 10 000 interventions in 2009 to 70 ELCAs performed per 10 000 interventions in 2018. The primary safety end point occurred in 4.2% of lesions and was higher than in cases where no ELCA was used (3.0% P<0.001). After adjusting for baseline differences among the subgroups who received ELCA, the in-stent restenosis group had the lowest rate of complications (odds ratio, 0.51 [95% CI, 0.42-0.63]), followed by the saphenous vein graft group (odds ratio, 0.72 [95% CI, 0.5-1]). The chronic total occlusion group had a higher risk for complications (odds ratio, 2.01 [95% CI, 1.61-2.40]). Conclusions: The use of ELCA has remained low but has increased in recent years. Complications are significantly higher when ELCA is used, but this effect is variable with respect to lesion subtype. ELCA is frequently used to treat in-stent restenosis with a low risk of complication. ELCA use during chronic total occlusion interventions is associated with a 2-fold increased risk of complications. Together these findings provide guidance for lesion selection to optimize safety with ELCA use.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] APPROPRIATENESS OF PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES: INSIGHTS FROM THE NCDR CATH/PCI REGISTRY
    Chan, Paul
    Patel, Manesh
    Klein, Lloyd W.
    Krone, Ronald J.
    Dehmer, Gregory J.
    Kennedy, Kevin
    Nallamothu, Brahmajee K.
    Weaver, W. Douglas
    Masoudi, Frederick
    Rumsfeld, John
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1151 - E1151
  • [2] CORONARY PERFORATION AFTER EXCIMER-LASER CORONARY ANGIOPLASTY - THE EXCIMER-LASER CORONARY ANGIOPLASTY REGISTRY EXPERIENCE
    HOLMES, DR
    REEDER, GS
    GHAZZAL, ZMB
    BRESNAHAN, JF
    KING, SB
    LEON, MB
    LITVACK, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (02) : 330 - 335
  • [3] Trends, Predictors and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention: Insights From NCDR® Cath PCI Registry
    Nairooz, Ramez
    McNulty, Edward
    Mohsen, Amr
    Parzynski, Craig
    Curtis, Jeptha
    Uretsky, Barry
    Hakeem, Abdul
    CIRCULATION, 2016, 134
  • [4] CLINICAL-RESULTS OF CORONARY EXCIMER-LASER ANGIOPLASTY - REPORT FROM THE EUROPEAN CORONARY EXCIMER-LASER ANGIOPLASTY REGISTRY
    BAUMBACH, A
    OSWALD, H
    KVASNICKA, J
    FLECK, E
    GESCHWIND, HJ
    OZBEK, C
    REIFART, N
    BERTRAND, ME
    KARSCH, KR
    EUROPEAN HEART JOURNAL, 1994, 15 (01) : 89 - 96
  • [5] Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry)
    Nairooz, Ramez
    Parzynski, Craig S.
    Curtis, Jeptha P.
    Mohsen, Amr
    McNulty, Edward
    Uretsky, Barry F.
    Hakeem, Abdul
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 37 - 45
  • [6] PERCUTANEOUS EXCIMER LASER CORONARY ANGIOPLASTY OF LESIONS NOT IDEAL FOR BALLOON ANGIOPLASTY
    COOK, SL
    EIGLER, NL
    SHEFER, A
    GOLDENBERG, T
    FORRESTER, JS
    LITVACK, F
    CIRCULATION, 1991, 84 (02) : 632 - 643
  • [7] EXCIMER LASER CORONARY ANGIOPLASTY - RESULTS IN RESTENOSIS VERSUS DENOVO CORONARY LESIONS
    REEDER, GS
    BRESNAHAN, JF
    HOLMES, DR
    LITVACK, F
    EIGLER, N
    MARGOLIS, J
    KRAUTHAMER, D
    ROTHBAUM, D
    LINNEMEIER, T
    KING, S
    DOUGLAS, J
    KENT, K
    SATLER, L
    SPENCER, W
    RAIZNER, A
    HASKELL, R
    MCNALLEY, P
    UNTEREKER, W
    VAWTER, M
    CUMMINS, F
    DORROS, G
    KRISHNASWAMI, V
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1992, 25 (03): : 195 - 199
  • [8] CORONARY EXCIMER LASER ANGIOPLASTY - RESULTS IN 223 PATIENTS FROM A MULTICENTER REGISTRY
    BITTL, JA
    SANBORN, TA
    HERSHMAN, RA
    SIEGEL, RM
    KRAMER, BL
    GINSBURG, R
    WATSON, LE
    TOBIS, J
    CIRCULATION, 1990, 82 (04) : 670 - 670
  • [9] EXCIMER LASER CORONARY ANGIOPLASTY
    MARGOLIS, JR
    MEHTA, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (15): : F3 - F11
  • [10] CORONARY EXCIMER LASER ANGIOPLASTY
    KARSCH, KR
    CIRCULATION, 1990, 82 (03) : 1076 - 1076